Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DaVita's share price for the quarter that ended in Mar. 2025 was $152.97. DaVita's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 77 Mil. Therefore, DaVita's market cap for the quarter that ended in Mar. 2025 was $11,821 Mil.
DaVita's quarterly market cap
declined
from Sep. 2024 ($13,545 Mil) to Dec. 2024 ($12,044 Mil) and
declined
from Dec. 2024 ($12,044 Mil) to Mar. 2025 ($11,821 Mil).
DaVita's annual market cap
increased
from Dec. 2022 ($6,751 Mil) to Dec. 2023 ($9,305 Mil) and
increased
from Dec. 2023 ($9,305 Mil) to Dec. 2024 ($12,044 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DaVita's Enterprise Value for Today is $24,823 Mil.
DaVita Market Cap Historical Data
The historical data trend for DaVita's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DaVita's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Market Cap distribution charts can be found below:
* The bar in red indicates where DaVita's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DaVita's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (NYSE:DVA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DaVita Market Cap Related Terms
Thank you for viewing the detailed overview of DaVita's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVA has been successfully added to your 